Omics CRO Services Global Market Opportunities And Strategies To 2034

Description

Omics CRO (Contract Research Organization) services refer to outsourced research solutions specializing in large-scale biological data analysis in fields such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. These services offer comprehensive support, encompassing sample processing, high-throughput data generation, bioinformatics analysis, and interpretation, to expedite research and development in pharmaceuticals, biotechnology, and personalized medicine. The primary purpose of omics CRO services is to enable organizations to conduct complex, high-volume omics studies efficiently without incurring significant investment in in-house infrastructure.

The omics CRO services market consists of sales, by entities (organizations, sole traders, or partnerships) of outsourced research and analytical services that apply different technologies for drug discovery, precision medicine, and biomarker identification.

The global omics CRO services market reached a value of nearly $34,209.94 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.55% since 2019. The market is expected to grow from $34,209.94 million in 2024 to $61,628.89 million in 2029 at a rate of 12.49%. The market is then expected to grow at a CAGR of 10.77% from 2029 and reach $ 102,794.04 million in 2034.

Favorable Government Initiatives

During the historic period, the favorable government initiatives supported the growth of the omics CRO services market. Favorable government initiatives, such as increased funding for precision medicine, grants for genomics research, and supportive regulatory frameworks, help omics CRO services by enabling expansion of advanced sequencing, biomarker discovery, and multi-omics capabilities. These policies reduce financial and operational barriers for CROs, encouraging innovation and adoption of cutting-edge technologies. Additionally, government-backed programs for clinical trials and data sharing accelerate research collaborations and global service reach. For instance, in September 2023, the National Institutes of Health (NIH), a US-based government agency, established consortium with an initial funding of $50.3 million to advance multi-omics research, focusing on integrating various omics data types to study health and disease in diverse populations. This initiative provides opportunities for CROs specializing in multi-omics services. Therefore, the favorable government initiatives drove the growth of the omics CRO services market.

Strategic Collaborations To Enhance Technology Integration

Key companies operating in the omics CRO services market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in November 2024, Frontage Laboratories, US-based contract research organization (CRO) providing integrated preclinical, clinical, and analytical services, partnered with Medicover Integrated Clinical Services (MICS), a Poland-based clinical and diagnostic services provider, his strategic partnership aims to integrate Frontage's clinical trial services with Medicover's advanced genomic testing solutions. Medicover, operating over 100 laboratories across 13 countries, provides comprehensive genomic analysis services, including next-generation sequencing (NGS), molecular pathology, and pharmacogenomics.

The global omics CRO services market is fairly concentrated, with a large player operating in the market. The top ten competitors in the market made up to 15.12% of the total market in 2024.

Omics CRO Services Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global omics CRO services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for omics CRO services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The omics CRO services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider omics CRO services market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of omics services, by technology platform, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of omics services, by technology platform, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for omics CRO services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type Of Omics Services: Genomics; Transcriptomics; Proteomics; Metabolomics; Lipidomics; Multiomics; Single-Cell Omics; Other Type Of Omics Services
2) By Technology Platform: Next-Generation Sequencing (NGS); Microarray Technology; Mass Spectrometry; Chromatography; Bioinformatics Tools; Other Technology Platforms
3) By Application: Drug Discovery And Development; Diagnostics; Personalized Medicine; Other Applications
4) By End Users: Research And Academic Institutions; Pharmaceutical And Biotechnology Companies; Clinical And Diagnostic Laboratories
Companies Mentioned: Labcorp Holding Inc. (including Covance); Thermo Fisher Scientific Inc. (PPD); Charles River Laboratories International Inc.; Eurofins Scientific SE; BGI Genomics Co. Ltd.
Countries: China; India; Japan; USA; Canada; UK; Germany; France; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; omics CRO services indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: PS5MOCSR01_O25Q4

1 Executive Summary

1.1 Omics CRO Services - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Omics CRO Services Market Definition And Segmentations
6.4 Market Segmentation By Type Of Omics Services
- 6.4.1 Genomics
- 6.4.2 Transcriptomics
- 6.4.3 Proteomics
- 6.4.4 Metabolomics
- 6.4.5 Lipidomics
- 6.4.6 Multiomics
- 6.4.7 Single-Cell Omics
- 6.4.8 Other Type Of Omics Services
6.5 Market Segmentation By Technology Platform
- 6.5.1 Next-Generation Sequencing (NGS)
- 6.5.2 Microarray Technology
- 6.5.3 Mass Spectrometry
- 6.5.4 Chromatography
- 6.5.5 Bioinformatics Tools
- 6.5.6 Other Technology Platforms
6.6 Market Segmentation By Application
- 6.6.1 Drug Discovery And Development
- 6.6.2 Diagnostics
- 6.6.3 Personalized Medicine
- 6.6.4 Other Applications
6.7 Market Segmentation By End Users
- 6.7.1 Research And Academic Institutions
- 6.7.2 Pharmaceutical And Biotechnology Companies
- 6.7.3 Clinical And Diagnostic Laboratories

7 Major Market Trends

7.1 Strategic Collaborations To Enhance Technology Integration
7.2 Strategic Collaborations Driving Advanced Spatial Transcriptomics
7.3 Next-Generation Organoid-Based Screening Solutions

8 Global Omics CRO Services Growth Analysis And Strategic Analysis Framework

8.1 Global Omics CRO Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End Users (B2B)
- 8.2.1 Research And Academic Institutions
- 8.2.2 Pharmaceutical And Biotechnology Companies
- 8.2.3 Clinical And Diagnostic Laboratories
8.3 Global Omics CRO Services Market Size And Growth Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Total Addressable Market for the Omics CRO Services Market
- 8.7.1 TAM Comparison Analysis

9 Global Omics CRO Services Market Segmentation

9.1 Global Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 China Market

10.1 Market Overview
- 10.1.1 Country Information
- 10.1.2 Market Information
- 10.1.3 Background Information
- 10.1.4 Government Initiatives
- 10.1.5 Regulations
- 10.1.6 Regulatory Bodies
- 10.1.7 Major Associations
- 10.1.8 Taxes Levied
- 10.1.9 Corporate Tax Structure
- 10.1.10 Investments
- 10.1.11 Major Companies
10.2 China Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.3 China Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.4 China Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.5 China Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.6 China Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.7 India Market
10.8 India Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.9 India Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.10 India Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.11 India Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.12 India Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Japan Market

11.1 Market Overview
- 11.1.1 Country Information
- 11.1.2 Market Information
- 11.1.3 Background Information
- 11.1.4 Government Initiatives
- 11.1.5 Regulations
- 11.1.6 Regulatory Bodies
- 11.1.7 Major Associations
- 11.1.8 Taxes Levied
- 11.1.9 Corporate Tax Structure
- 11.1.10 Investments
- 11.1.11 Major Companies
11.2 Japan Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.3 Japan Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Japan Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Japan Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Japan Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Europe Market

12.1 Market Overview
- 12.1.1 Region Information
- 12.1.2 Market Information
- 12.1.3 Background Information
- 12.1.4 Government Initiatives
- 12.1.5 Regulations
- 12.1.6 Regulatory Bodies
- 12.1.7 Major Associations
- 12.1.8 Taxes Levied
- 12.1.9 Corporate Tax Structure
- 12.1.10 Investments
- 12.1.11 Major Companies
12.2 Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.3 Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.7 Europe Omics CRO Services Market: Country Analysis
12.8 UK Market
12.9 UK Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 UK Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 UK Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 UK Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Market
12.15 Germany Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 Germany Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 Germany Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Germany Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Germany Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 France Market
12.21 France Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 France Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 France Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 France Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 France Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Italy Market
12.27 Italy Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.28 Italy Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.29 Italy Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.30 Italy Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.31 Italy Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.32 Spain Market
12.33 Spain Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.34 Spain Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.35 Spain Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.36 Spain Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.37 Spain Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.38 Rest Of Europe Market
12.39 Rest Of Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.40 Rest Of Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.41 Rest Of Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.42 Rest Of Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.43 Rest Of Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 USA Market

13.1 Market Overview
- 13.1.1 Country Information
- 13.1.2 Market Information
- 13.1.3 Background Information
- 13.1.4 Government Initiatives
- 13.1.5 Regulations
- 13.1.6 Regulatory Bodies
- 13.1.7 Major Associations
- 13.1.8 Taxes Levied
- 13.1.9 Corporate Tax Structure
- 13.1.10 Investments
- 13.1.11 Major Companies
13.2 USA Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.3 USA Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 USA Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 USA Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 USA Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Canada Market

14.1 Market Overview
- 14.1.1 Country Information
- 14.1.2 Market Information
- 14.1.3 Background Information
- 14.1.4 Government Initiatives
- 14.1.5 Regulations
- 14.1.6 Regulatory Bodies
- 14.1.7 Major Associations
- 14.1.8 Taxes Levied
- 14.1.9 Corporate Tax Structure
- 14.1.10 Investments
- 14.1.11 Major Companies
14.2 Canada Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.3 Canada Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Canada Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Canada Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 Canada Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 Global Competitive Landscape And Company Profiles

15.1 Company Profiles
15.2 Labcorp Holding Inc. (including Covance)
- 15.2.1 Company Overview
- 15.2.2 Products And Services
- 15.2.3 Financial Overview
15.3 Thermo Fisher Scientific Inc. (PPD)
- 15.3.1 Company Overview
- 15.3.2 Products And Services
- 15.3.3 Business Strategy
- 15.3.4 Financial Overview
15.4 Charles River Laboratories International Inc.
- 15.4.1 Company Overview
- 15.4.2 Products And Services
- 15.4.3 Financial Overview
15.5 Eurofins Scientific SE
- 15.5.1 Company Overview
- 15.5.2 Products And Services
- 15.5.3 Financial Overview
15.6 BGI Genomics Co. Ltd.
- 15.6.1 Company Overview
- 15.6.2 Products And Services
- 15.6.3 Financial Overview

16 Other Major And Innovative Companies

16.1 Novogene Co. Ltd.
- 16.1.1 Company Overview
- 16.1.2 Products And Services
16.2 GENEWIZ from Azenta
- 16.2.1 Company Overview
- 16.2.2 Products And Services
16.3 Frontage Laboratories
- 16.3.1 Company Overview
- 16.3.2 Products And Services
16.4 Somalogic Inc. (SomaScan(R))
- 16.4.1 Company Overview
- 16.4.2 Products And Services
16.5 Metabolon Inc.
- 16.5.1 Company Overview
- 16.5.2 Products And Services

17 Information On Strengths And Weaknesses Of Top 10 Global Companies

17.1 Labcorp Holding Inc. (including Covance)
- 17.1.1 Strengths
- 17.1.2 Weaknesses
17.2 Thermo Fisher Scientific Inc. (PPD)
- 17.2.1 Strengths
- 17.2.2 Weaknesses
17.3 Charles River Laboratories
- 17.3.1 Strengths
- 17.3.2 Weaknesses
17.4 Eurofins Scientific SE
- 17.4.1 Strengths
- 17.4.2 Weaknesses
17.5 BGI Genomics Co. Ltd.
- 17.5.1 Strengths
- 17.5.2 Weaknesses
17.6 Novogene Co. Ltd.
- 17.6.1 Strengths
- 17.6.2 Weaknesses
17.7 GENEWIZ from Azenta
- 17.7.1 Strengths
- 17.7.2 Weaknesses
17.8 Frontage Laboratories
- 17.8.1 Strengths
- 17.8.2 Weaknesses
17.9 Somalogic Inc. (SomaScan(R))
- 17.9.1 Strengths
- 17.9.2 Weaknesses
17.10 Metabolon Inc.
- 17.10.1 Strengths
- 17.10.2 Weaknesses

18 Information On AI/ML Capabilities Of Top 10 Global Companies

18.1 Labcorp Holding Inc. (Including Covance)
- 18.1.1 Bioinformatics And Genomics Pipelines (NGS, Expression, Multi-Omics)
- 18.1.2 Clinical and Real-World Data (RWD) with Predictive Analytics
- 18.1.3 Digital Pathology And Image-Based AI
- 18.1.4 Cloud Infrastructure and Generative-AI Clinician Tools
- 18.1.5 Partnerships And External AI/ML Collaborations
18.2 Thermo Fisher Scientific Inc. (PPD)
- 18.2.1 Accelerator(TM) Drug Development Platform
- 18.2.2 AI-Powered Clinical Trial Forecasting
- 18.2.3 PPD(TM) TrueCast AI Solution
- 18.2.4 Partnership with OpenAI
- 18.2.5 Integration of AI in Laboratory Services
18.3 Charles River Laboratories
- 18.3.1 Logica: AI-Powered Drug Discovery Platform
- 18.3.2 Collaborations with Aitia and Related Sciences
- 18.3.3 Integration of Omics and New Approach Methodologies
18.4 Eurofins Scientific SE
- 18.4.1 Eurofins DiscoveryAI: SAFIRE Platform
- 18.4.2 Eurofins Viracor Bioinformatics & AI Center of Excellence
- 18.4.3 Cloud-Based Data Analysis Infrastructure
18.5 BGI Genomics Co. Ltd.
- 18.5.1 GeneT: AI-Powered Genomic Consultation Platform
- 18.5.2 iGeneT Pro: Comprehensive Bioinformatics Analysis
- 18.5.3 133111i Multi-Omics Precision Health Management System
- 18.5.4 Dr. Tom: Multi-Omics Data Visualization System
- 18.5.5 Multi-Omics Services for Research and Drug Discovery
18.6 Novogene Co. Ltd.
- 18.6.1 NovoMagic: Cloud-Based Bioinformatics Platform
- 18.6.2 Novi: AI-Powered RNA-Seq Analysis Assistant
- 18.6.3 C2-Intelligence Platform: AI-Powered Cancer Detection
- 18.6.4 Multi-Omics Services for Research and Drug Discovery
18.7 GENEWIZ from Azenta
- 18.7.1 Strategic Partnership with Form Bio
- 18.7.2 Advanced Sequencing Technologies
- 18.7.3 3. Comprehensive Bioinformatics Solutions
- 18.7.4 Multi-Omics Services for Research and Drug Discovery
18.8 Frontage Laboratories
- 18.8.1 Genomics and Omics Services
- 18.8.2 Drug Discovery and Development Services
- 18.8.3 Biomarker and Precision Medicine
- 18.8.4 AI/ML Integration in Omics Services
18.9 Somalogic Inc. (SomaScan(R))
- 18.9.1 AI/ML Integration in SomaScan(R) Proteomics
- 18.9.2 Omics CRO Servicesand Capabilities
- 18.9.3 High-Throughput Proteomics
- 18.9.4 Biomarker Discovery
- 18.9.5 Clinical and Translational Research
18.10 Metabolon Inc.
- 18.10.1 Automate Data Curation
- 18.10.2 Identify Biochemical Signatures
- 18.10.3 Anomaly Detection

19 Information On Innovations By Top 10 Global Companies Including Description Of Type Of Innovation

19.1 Labcorp Holding Inc. (Including Covance)
- 19.1.1 Next-Generation Sequencing (NGS) Panel Advancements
19.2 Thermo Fisher Scientific Inc. (PPD)
- 19.2.1 Expansion of Bioanalytical Laboratory Services in Europe
- 19.2.2 R&D Partnership with AstraZeneca BioVentureHub
19.3 Charles River Laboratories
- 19.3.1 Omics and New Approach Methodologies (NAMs) Integration
- 19.3.2 Automation in Spatial Biology
19.4 Eurofins Scientific SE
- 19.4.1 Partnership with Hurdle to Enhance Omics Testing Access
- 19.4.2 Integration of Omics Technologies with New Approach Methodologies (NAMs)
19.5 BGI Genomics Co. Ltd.
- 19.5.1 Collaboration with Saudi Arabia's National Unified Procurement Company
19.6 Novogene Co. Ltd.
- 19.6.1 Launch of Spatial Transcriptomics Service
- 19.6.2 Establishment of Novogene Korea Limited
- 19.6.3 Certification as Olink(R) Certified Service Provider
19.7 GENEWIZ from Azenta
- 19.7.1 Launch of Clinical Long-Read Whole Genome Sequencing Test
- 19.7.2 Strategic Partnership with Form Bio for AAV Gene Therapy
- 19.7.3 GENEWIZ Week 2025 Workshops
19.8 Frontage Laboratories
- 19.8.1 Strategic Collaboration with Medicover Integrated Clinical Services
- 19.8.2 Participation in the 2025 EMGS Annual Meeting
- 19.8.3 Expansion of Global Drug Discovery and DMPK Leadership
19.9 Somalogic Inc. (SomaScan(R))
- 19.9.1 Expansion of SomaScan(R) 11K Platform
- 19.9.2 Early Access Program with Illumina Sequencers
- 19.9.3 SomaScan(R) Assay Powers Key Insights into Semaglutide Treatment
- 19.9.4 Illumina's Acquisition of SomaLogic
19.10 Metabolon Inc.
- 19.10.1 Launch of Integrated Bioinformatics Platform
- 19.10.2 Introduction of 4-Week Turnaround Time for Commercial Projects
- 19.10.3 Launch of Microbiome Research Solution
- 19.10.4 Expansion of Integrated Bioinformatics Platform

20 Information On Technologies Used Specifically For Proteomics, Metabolomics And Lipidomics Platforms/Projects By Top 10 Global Companies

20.1 Labcorp Holding Inc. (including Covance)
- 20.1.1 Proteomics Technologies
- 20.1.2 Metabolomics Technologies
- 20.1.3 Lipidomics Technologies
20.2 Thermo Fisher Scientific Inc.
- 20.2.1 Proteomics Technologies
- 20.2.2 Metabolomics Technologies
- 20.2.3 Lipidomics Technologies
20.3 Charles River Laboratories
- 20.3.1 Proteomics Technologies
- 20.3.2 Metabolomics Technologies
- 20.3.3 Lipidomics Technologies
20.4 Eurofins Scientific SE
- 20.4.1 Proteomics Technologies
- 20.4.2 Metabolomics Technologies
- 20.4.3 Lipidomics Technologies
20.5 BGI Genomics Co. Ltd.
- 20.5.1 Proteomics Technologies
- 20.5.2 Metabolomics Technologies
- 20.5.3 Lipidomics Technologies
20.6 Novogene Co. Ltd.
- 20.6.1 Proteomics Technologies
- 20.6.2 Metabolomics Technologies
- 20.6.3 Lipidomics Technologies
20.7 GENEWIZ from Azenta
- 20.7.1 Proteomics Technologies
- 20.7.2 Metabolomics Technologies:
- 20.7.3 Lipidomics Technologies:
20.8 Frontage Laboratories
- 20.8.1 Proteomics Technologies
- 20.8.2 Metabolomics Technologies
- 20.8.3 Lipidomics Technologies
20.9 Somalogic Inc. (SomaScan)
- 20.9.1 Proteomics Technologies
- 20.9.2 Metabolomics Technologies
- 20.9.3 Lipidomics Technologies
20.10 Metabolon Inc.
- 20.10.1 Proteomics Technologies
- 20.10.2 Metabolomics Technologies
- 20.10.3 Lipidomics Technologies

21 Information On Overall Capabilities And Technologies Including Coverage, Dynamic Range, Sensitivity And Reproducibility For Top 10 Global Companies

21.1 Labcorp Holding Inc. (including Covance)
- 21.1.1 Overall Capabilities & Technologies
- 21.1.2 Coverage
- 21.1.3 Dynamic Range
- 21.1.4 Sensitivity
- 21.1.5 Reproducibility
21.2 Thermo Fisher Scientific Inc. (PPD)
- 21.2.1 Overall Capabilities & Technologies
- 21.2.2 Coverage
- 21.2.3 Dynamic Range
- 21.2.4 Sensitivity
- 21.2.5 Reproducibility
21.3 Charles River Laboratories
- 21.3.1 Overall Capabilities & Technologies
- 21.3.2 Coverage
- 21.3.3 Dynamic Range
- 21.3.4 Sensitivity
- 21.3.5 Reproducibility
21.4 Eurofins Scientific SE
- 21.4.1 Overall Capabilities & Technologies
- 21.4.2 Coverage
- 21.4.3 Dynamic Range
- 21.4.4 Sensitivity
- 21.4.5 Reproducibility
21.5 BGI Genomics Co. Ltd.
- 21.5.1 Overall Capabilities & Technologies
- 21.5.2 Coverage
- 21.5.3 Dynamic Range
- 21.5.4 Sensitivity
- 21.5.5 Reproducibility
21.6 Novogene Co. Ltd.
- 21.6.1 Overall Capabilities & Technologies
- 21.6.2 Coverage
- 21.6.3 Dynamic Range
- 21.6.4 Sensitivity
- 21.6.5 Reproducibility
21.7 GENEWIZ from Azenta
- 21.7.1 Overall Capabilities & Technologies
- 21.7.2 Coverage
- 21.7.3 Dynamic Range
- 21.7.4 Sensitivity
- 21.7.5 Reproducibility
21.8 Frontage Laboratories
- 21.8.1 Overall Capabilities & Technologies
- 21.8.2 Coverage
- 21.8.3 Dynamic Range
- 21.8.4 Sensitivity
- 21.8.5 Reproducibility
21.9 Somalogic Inc. (SomaScan)
- 21.9.1 Overall Capabilities & Technologies
- 21.9.2 Coverage
- 21.9.3 Dynamic Range
- 21.9.4 Sensitivity
- 21.9.5 Reproducibility
21.10 Metabolon Inc.
- 21.10.1 Overall Capabilities & Technologies
- 21.10.2 Coverage
- 21.10.3 Dynamic Range
- 21.10.4 Sensitivity
- 21.10.5 Reproducibility

22 List Of Key Players In The Omics CRO Services Market

22.1 Key Players In The Omics Contract Research Organization (CRO) Services Market

23 Europe Competitive Landscape And Company Profiles

23.1 Company Profiles
23.2 Charles River Laboratories International Inc.
- 23.2.1 Company Overview
- 23.2.2 Products And Services
23.3 Labcorp Holdings Inc.
- 23.3.1 Company Overview
- 23.3.2 Products And Services
23.4 Thermo Fisher Scientific Inc.
- 23.4.1 Company Overview
- 23.4.2 Products And Services
23.5 Eurofins Scientific SE.
- 23.5.1 Company Overview
- 23.5.2 Products And Services
23.6 BGI Genomics Co. Ltd.
- 23.6.1 Company Overview
- 23.6.2 Products And Services
23.7 Novogene Co. Ltd.
- 23.7.1 Company Overview
- 23.7.2 Products And Services
23.8 GENEWIZ from Azenta
- 23.8.1 Company Overview
- 23.8.2 Products And Services
23.9 Frontage Laboratories
- 23.9.1 Company Overview
- 23.9.2 Products And Services
23.10 Somalogic Inc.
- 23.10.1 Company Overview
- 23.10.2 Products And Services
23.11 Metabolon Inc.
- 23.11.1 Company Overview
- 23.11.2 Products And Services

24 UK Competitive Landscape And Company Profiles

24.1 Short Profiles
24.2 Eurofins Scientific SE
- 24.2.1 Company Overview
- 24.2.2 Products And Services
24.3 Charles River Laboratories Company
- 24.3.1 Company Overview
- 24.3.2 Products And Services
24.4 Labcorp Holding Inc.
- 24.4.1 Company Overview
- 24.4.2 Products And Services
24.5 Thermo Fisher Scientific Inc.
- 24.5.1 Company Overview
- 24.5.2 Products And Services
24.6 BGI Genomics Co. Ltd.
- 24.6.1 Company Overview
- 24.6.2 Products And Services
24.7 Novogene Co. Ltd.
- 24.7.1 Company Overview
- 24.7.2 Products And Services
24.8 GENEWIZ from Azenta
- 24.8.1 Company Overview
- 24.8.2 Products And Services
24.9 Frontage Laboratories
- 24.9.1 Company Overview
- 24.9.2 Products And Services
24.10 Metabolon Inc.
- 24.10.1 Company Overview
- 24.10.2 Products And Services
24.11 Somalogic Inc.
- 24.11.1 Company Overview
- 24.11.2 Products And Services

25 Germany Competitive Landscape And Company Profiles

25.1 Short Profiles
25.2 Labcorp Holding Inc. (including Covance)
- 25.2.1 Company Overview
- 25.2.2 Products And Services
25.3 Thermo Fisher Scientific Inc. (PPD)
- 25.3.1 Company Overview
- 25.3.2 Products And Services
25.4 Eurofins Scientific SE
- 25.4.1 Company Overview
- 25.4.2 Products And Services
25.5 Charles River Laboratories
- 25.5.1 Company Overview
- 25.5.2 Products And Services
25.6 BGI Genomics Co. Ltd.
- 25.6.1 Company Overview
- 25.6.2 Products And Services
25.7 Novogene Co. Ltd.
- 25.7.1 Company Overview
- 25.7.2 Products And Services
25.8 GENEWIZ from Azenta
- 25.8.1 Company Overview
- 25.8.2 Products And Services
25.9 Somalogic Inc. (SomaScan(R))
- 25.9.1 Company Overview
- 25.9.2 Products And Services
25.10 Centogene GmbH
- 25.10.1 Company Overview
- 25.10.2 Products And Services
25.11 Frontage Laboratories
- 25.11.1 Company Overview
- 25.11.2 Products And Services

26 USA Competitive Landscape And Company Profiles

26.1 Short Profiles
26.2 Labcorp Holding Inc. (including Covance)
- 26.2.1 Company Overview
- 26.2.2 Products And Services
26.3 Thermo Fisher Scientific Inc. (PPD)
- 26.3.1 Company Overview
- 26.3.2 Products And Services
26.4 Charles River Laboratories
- 26.4.1 Company Overview
- 26.4.2 Products And Services
26.5 Eurofins Scientific SE
- 26.5.1 Company Overview
- 26.5.2 Products And Services
26.6 BGI Genomics Co. Ltd.
- 26.6.1 Company Overview
- 26.6.2 Products And Services
26.7 Novogene Co. Ltd.
- 26.7.1 Company Overview
- 26.7.2 Products And Services
26.8 GENEWIZ from Azenta
- 26.8.1 Company Overview
- 26.8.2 Products And Services
26.9 Frontage Laboratories
- 26.9.1 Company Overview
- 26.9.2 Products And Services
26.10 Somalogic Inc. (SomaScan(R))
- 26.10.1 Company Overview
- 26.10.2 Products And Services
26.11 Metabolon Inc.
- 26.11.1 Company Overview
- 26.11.2 Products And Services

27 Japan Competitive Landscape And Company Profiles

27.1 Short Profiles
27.2 Eurofins Scientific SE
- 27.2.1 Company Overview
- 27.2.2 Products And Services
27.3 Charles River Laboratories
- 27.3.1 Company Overview
- 27.3.2 Products And Services
27.4 Thermo Fisher Scientific Inc. (PPD)
- 27.4.1 Company Overview
- 27.4.2 Products And Services
27.5 BGI Genomics Co. Ltd.
- 27.5.1 Company Overview
- 27.5.2 Products And Services
27.6 Labcorp Holding Inc. (including Covance)
- 27.6.1 Company Overview
- 27.6.2 Products And Services
27.7 Novogene Co. Ltd.
- 27.7.1 Company Overview
- 27.7.2 Products And Services
27.8 GENEWIZ from Azenta
- 27.8.1 Company Overview
- 27.8.2 Products And Services
27.9 Frontage Laboratories
- 27.9.1 Company Overview
- 27.9.2 Products And Services
27.10 Somalogic Inc. (SomaScan(R))
- 27.10.1 Company Overview
- 27.10.2 Products And Services
27.11 Centogene GmbH
- 27.11.1 Company Overview
- 27.11.2 Products And Services

28 List Of Key Omics CRO Services Companies For The Countries

28.1.1 France
28.1.2 Italy
28.1.3 Spain
28.1.4 Rest Of Europe
28.1.5 Canada
28.1.6 China
28.1.7 India

29 Current Uses Of AI/ML In Technology Platforms In Omics CRO Services Market

29.1 Next-Generation Sequencing (NGS)
29.2 Microarray Technology
29.3 Mass Spectrometry
29.4 Chromatography
29.5 Bioinformatics Tools
29.6 Other Technology Platforms

30 List Of Largest Customer Companies

31 Relative Demand/Size Of Service

31.1 Target Validation
31.2 De-Risking Projects
31.3 Hit-To-Lead
31.4 Biomarker Identification
31.5 Manufacturing Process Improvements
31.6 Drug Substance Analysis
31.7 Toxicology Evaluations
31.8 Visualization Of Data
31.9 AI/ML Interpretations

32 Usage Frequency Of AI/ML In Decision Making Across Omics CRO Projects

32.1 Genomics: Analyze Sequencing Data, And Identify Gene Patterns
32.2 Transcriptomics: Interpret RNA Data, And Quantify Expression
32.3 Proteomics: Classify Proteins, And Detect Modifications
32.4 Metabolomics: Analyze Metabolite Profiles, And Identify Patterns
32.5 Multi-Omics Integration: Integrate Datasets, And Avoid Outcome Incidents
32.6 Epigenomics: AI/ML in Chromatin & DNA Modification Analysis
32.7 Microbiomics: AI/ML in Microbiome Composition and Function
32.8 Pharmacogenomics & Toxicogenomics: AI/ML in Drug Response Prediction
32.9 Single-Cell Omics: AI/ML in Cell-Type Specific Analysis
32.10 Immunomics: AI/ML in Immune Repertoire and Immune Response Profiling

33 Unmet Needs Of The Omics CRO Services Market

33.1 Complexity and High Standards
33.2 Customized, Client-Centric Solutions
33.3 Efficient Data Management and Security
33.4 Faster, Cost-Effective Turnaround
33.5 Comprehensive Coverage Across Drug Development Phases
33.6 Patient Stratification and Recruitment

34 Opportunities And Threats To The Omics CRO Services Market

34.1 Opportunities
- 34.1.1 Expansion of Precision and Personalized Medicine
- 34.1.2 Rising Adoption of AI and Data Analytics
- 34.1.3 Increasing Outsourcing by Biotech and Pharma Firms
- 34.1.4 Growing Global Demand for Multi-omics Clinical Trials
- 34.1.5 Investment and Partnerships Across Emerging Markets
34.2 Threats
- 34.2.1 High Cost and Complexity of Omics Technologies
- 34.2.2 Data Integration Challenges
- 34.2.3 Talent scarcity
- 34.2.4 Ethical And Privacy Concerns
- 34.2.5 Rising competition

35 Technologies Change In The Omics CRO Services Market

35.1 Mass Spectrometry (MS) Platforms
35.2 Chromatography Systems
35.3 Bioinformatics and Data Analysis Pipelines
35.4 Sample Preparation and Handling Technologies
35.5 Proteomics Quantitation Methods
35.6 Metabolomics and Lipidomics Platforms
35.7 Multi-Omics Integration Tools
35.8 Data Storage and Sharing Technologies

36 Expertise Necessary To Compete In The Omics CRO Services Market

36.1 Core Technical Expertise
36.2 Multi-Omics Data Integration
36.3 End-to-End Service Delivery
36.4 Regulatory and Domain Knowledge
36.5 Emerging Trends and Strategic Positioning

37 Small Players In The Omics CRO Services Market

37.1 North America
- 37.1.1 Dalton Bioanalytics
- 37.1.2 Sapient Bioanalytics
- 37.1.3 MS Bioworks Company
- 37.1.4 Panome Bio
- 37.1.5 Allumiqs
37.2 Europe
- 37.2.1 OmicScouts GmbH
- 37.2.2 Sciomics GmbH
- 37.2.3 PreOmics GmbH
- 37.2.4 Biognosys AG
- 37.2.5 GenomeScan

38 Competitive Benchmarking

39 Competitive Dashboard

40 Key Mergers And Acquisitions

40.1 Mapmygenome Acquired Microbiome Insights
40.2 Momentum Biotechnologies Acquired OmicScouts GmbH
40.3 Crown Bioscience Acquired Indivumed GmbH

41 Recent Development In Omics CRO Services Market

41.1 Cutting-Edge Facility Supports End-to-End Multi-Omics Research and Product InnovationI

42 Opportunities And Strategies

42.1 Global Omics CRO Services Market In 2029 - Countries Offering Most New Opportunities
42.2 Global Omics CRO Services Market In 2029 - Segments Offering Most New Opportunities
42.3 Global Omics CRO Services Market In 2029 - Growth Strategies
- 42.3.1 Market Trend Based Strategies
- 42.3.2 Competitor Strategies

43 Omics CRO Services Market, Conclusions And Recommendations

43.1 Conclusions
43.2 Recommendations
- 43.2.1 Product
- 43.2.2 Place
- 43.2.3 Price
- 43.2.4 Promotion
- 43.2.5 People

44 Appendix

44.1 Geographies Covered
44.2 Market Data Sources
44.3 Research Methodology
44.4 Currencies
44.5 The Business Research Company
44.6 Copyright and Disclaimer